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Women with a known BRCA 1 or BRCA 2 genetic mutation are at an increased risk for the 
development of cancer, most commonly breast and uterine types. Risk reduction strategies to 
manage cancer risk include increased medical surveillance and various preventive surgeries.  
This is a deeply personal decision and one that is influenced by a variety of factors. The aim of 
this literature review is to identify the key factors impacting the decision-making process of a 
woman with a BRCA mutation and how a woman ultimately decides between the cancer risk 
management strategies. Six electronic databases were used to obtain the highest levels of 
evidence to answer the clinical question at stake. A total of 13 research articles met inclusion 
criteria and were examined for key findings. Upon review of the literature, it is evident that 
themes exist when examining the decision-making process of women carrying a BRCA 
mutation. The most common factor appearing to influence women’s decisions is when a woman 
has experienced a family member diagnosed with cancer or has experienced the death of a family 
member from cancer; these women tend to choose a preventive surgery. Other factors that affect 
women in their decision-making are their stage of life with regards to relationship status and 
parity, the value placed on body image and the female body parts, and a variety of psychosocial 
factors.  Medical professionals can also heavily influence how women make decisions. The 
findings of this review are significant for all health care providers as they engage in shared 
decision-making and support women with a BRCA genetic mutation who must decide upon a 
risk reducing strategy.  
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Choosing Between Medical Surveillance and Preventive Surgical Interventions Among 
Asymptomatic BRCA Positive Women 
The average lifetime risk of developing breast cancer for an American woman is 
approximately 12%, while the average lifetime risk of developing ovarian cancer is 
approximately 2% (ACOG, 2018). The risk of developing breast and ovarian cancer substantially 
increases in women who are found to be carriers of the BRCA gene. Women who test positive 
for the BRCA mutation have a 50%-80% lifetime risk of being diagnosed with breast cancer by 
the age of 85 (Johns et al., 2017). Women with a BRCA1 gene have a 39%-46% risk of 
developing ovarian cancer by the age of 70, while women with a BRCA2 gene have a 10%-27% 
risk of developing ovarian cancer (ACOG, 2018). Though the statistical odds distinctly 
demonstrate an increased risk of cancer among BRCA positive women, how a woman decides to 
gauge her own cancer risk and determine a treatment plan varies.   
When a woman learns that she is a carrier of a BRCA mutation, the decision-making 
process begins. A woman must first understand the options available to reduce cancer risk; this 
includes several risk-reducing surgical procedures and multiple methods to increase medical 
surveillance. Deciding which option to pursue is a highly personal decision with a myriad of 
influencing factors. Previous research has demonstrated that the trajectory of the decision-
making process follows a traditional medical model and is somewhat monomorphic for all 
women; however, more recent literature alludes to the fact that the process is much more 
individualized, rooted in the experiences of women’s everyday lives (Hesse-Biber, 2016).  
Ultimately, a woman must choose a path that best aligns with her personal desires and values.  
Through this literature review, key factors are revealed that affect women in deciding between 




The BRCA mutation places a woman at an increased risk for hereditary cancers, 
most commonly, breast and ovarian cancer (ACOG, 2018). Other cancers that are a possibility 
include those in the fallopian tubes, peritoneum, pancreas, and skin (ACOG, 2018). The function 
of BRCA1 and BRCA2 genes are to suppress tumors by repairing DNA breaks that can lead to 
cancer cell proliferation (ACOG, 2018). If these genes are found to have a mutation, they don’t 
work properly which results in accelerated expansion of cells, often resulting in cancer (ACOG, 
2018). This is the reason women are at a higher risk for a plethora of cancers when a mutation in 
the BRCA1 or BRCA2 gene occurs.  
BRCA mutations are transmitted via an autosomal dominant pattern of inheritance from 
either parent (USPSTF, 2019). According to the American College of Obstetrics and Gynecology 
(2018), anywhere from one in 300 people to one in 800 people are found to have a BRCA1 or 
BRCA2 genetic mutation. The most common ethnicities linked to the mutation are Eastern or 
Central European Jewish, French Canadian, and Icelandic (ACOG, 2018). Routine testing for the 
gene is not recommended; however, certain scenarios should prompt an individual to be tested. 
Genetic testing for the BRCA1 and BRCA2 mutation is highly sensitive and specific 
(USPSTF, 2019). According to the United States Preventive Services Task Force (2019), testing 
for the BRCA1/2 gene should be completed in those with a known family history of the gene, 
including male relatives. If the status of the mutation is not known in families, testing should 
begin only in individuals with known BRCA-related cancers in order to detect the presence of 
the gene (USPSTF, 2019). For women where family history information is limited or unknown, 
there is no clear direction for the assessment of the mutation (USPSTF, 2019). Access to genetic 
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counseling and recommended interventions for a BRCA mutation should also be considered 
prior to testing (USPSTF, 2019).  
Once a woman chooses to undergo testing and receives positive results, the 
process begins to decipher personal cancer risk and determine optimal treatment outcomes.  
Learning of a BRCA mutation is often a stressful experience for women. A woman’s pathway to 
making decisions about cancer risk management is complex, highly personal and involves an 
array of factors. A review of the literature depicts various factors that play of role in motivating 
women to choose between medical surveillance and a preventative surgical procedure. 
Surveillance or Surgery 
One pathway after discovery of a BRCA positive screen is to participate in ongoing 
medical surveillance. This route allows a woman to undergo frequent medical examinations and 
imaging to closely monitor for the development of cancer. Specific guidelines exist for the 
BRCA positive woman in regards to recommended medical surveillance and/or prophylactic 
treatment. The current guidelines by the National Comprehensive Cancer Network (NCCN) 
recommend a clinical breast exam by a provider every 6 months, an annual mammogram, and a 
breast MRI beginning at age 30 (Johns et al., 2017). The American Society of Breast Surgeons 
(2019) differ slightly, recommending those women with hereditary susceptibility should have an 
annual MRI starting at age 25 and annual mammography starting at age 30. Women should be 
offered yearly supplemental imaging, including contrast-enhanced breast magnetic resonance 
imaging, whole-breast ultrasound, molecular breast imaging, and contrast-enhanced 
mammography (ASBrS, 2019). Less research has been completed on ovarian cancer 
surveillance; therefore, the salpingo-oophorectomy procedure is the recommended approach to 
manage cancer risk. (Johns et al., 2017).  
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The second pathway to manage cancer risk with a BRCA mutation consists of multiple 
surgical options; this includes a single or double mastectomy, a hysterectomy, and a 
oophorectomy (Hesse-Biber, 2014). A mastectomy is a procedure that removes the breast 
components. Both a total mastectomy and a partial mastectomy exist; however, for purposes of 
prophylaxis, a total mastectomy is recommended to prevent any chance of cancer 
(Breastcancer.org, 2020). A total hysterectomy is the surgical procedure to remove the uterus and 
the cervix (Eske, 2020). This can also be combined with salpingo-oophorectomy which involves 
removing one or both of a woman’s ovaries and fallopian tubes (Eske, 2020).   
The decision to choose a surgical option is a complex one. Women must first understand 
each procedure and weigh the benefits and risks of each one. Women must also consider how 
these procedures may affect future fertility and body image; two factors which have different 
meaning for every woman. Women should consider body image, the risk of surgical 
complications and the potential life expectancy gain (Salhab et al., 2010). A risk-reducing 
surgery has been found to significantly decrease the risk of developing breast and ovarian cancer 
in high-risk individuals (Portnoy et al., 2015). In fact, risk reduction for breast and ovarian 
cancer after prophylactic mastectomy is thought to be 90%, and for salpingo-oophorectomy up to 
80% (Johns et al., 2017). If the reduction in cancer risk is proven to be substantial among these 
procedures, then why do women opt against them? The review of the literature as described later 
in the paper helps answer this question and decipher the decision-making process for women.  
Purpose/Clinical Question 
Based upon the phenomena of interest, the following clinical question was developed in PIO 
format to direct the systematic review of the literature: How do asymptomatic women with a 
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BRCA positive mutation choose between medical surveillance and preventive surgical 
intervention/procedures?  
Clinical Significance for Advanced Practice  
 Genetic counseling and testing have become increasingly prevalent within the medical 
world. Often, the first point of contact for testing or referral is in the primary care setting. 
Females will seek the knowledge and advice of providers regarding BRCA genetic testing; this 
includes whether to complete the testing, what the results mean, and the options available if 
positive results are received. A lack of knowledge surrounding the BRCA gene and how women 
make decisions regarding treatment options creates a barrier to providing exceptional care and 
maximizing cancer prevention. One participant in a study by Leonarczyk and Mawn (2015) 
validated this idea:  
Having a place to go where you feel like someone is knowledgeable about all the options 
is really helpful, and I felt like my nurse practitioner that I see - I actually seem to be 
educating her a bit- in the options and the whole process, and that can give you a little bit 
of a sense of – not mistrust, but just feeling, you know, that you aren’t necessarily being 
taken care of – that you are kind of guiding the ship. (p. 76) 
A patient should not have to feel as though they are educating their health care provider or 
navigating the process alone. Advanced practice providers should understand the whole process 
and decision-making from a women’s standpoint in order to better guide and support women.   
 Clinician recommendations are often based solely on physical health outcomes, however 
the overall impact on a woman’s self-identity, emotional-well-being, and interpersonal 
relationships should also be considered (Howard et al., 2011). While genetic counselors may be 
available in some locations to support women, the primary care provider may be the point of 
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contact in rural or underserved communities; therefore, having the awareness and knowledge 
surrounding decision-making among BRCA positive woman allows the primary care provider to 
play a significant role in empowering and supporting these patients.   
Methods 
An extensive literature search was completed between the dates of October 19, 
2020 and November 29, 2020 as it pertains to the clinical question. The databases utilized 
in this search included Academic Search Premier, CINAHL, Health Source: 
Nursing/Academic Edition, MEDLINE, PubMed, and PsycARTICLES. The topic areas 
covered by each database along with the restrictions added to the search criteria are 
displayed in Table 1 of the appendix. The dates of each search, the specific search terms, 
and the resulting number of hits are included in Table 2 of the appendix. Search term 
combinations included “BRCA gene,” “BRCA positive women AND decision making,” 
“BRCA mutation AND decision making,” “BRCA gene AND risk reduction strategies,” 
BRCA gene AND surgical intervention,” “BRCA gene AND surveillance,” “BRCA 
positive AND decision making,” and “preventive surgery AND BRCA gene.” The limits 
applied to the search with each database included the dates of 2009 to 2020, the English 
language, and peer-reviewed articles. 
Once the number of hits for each database were recorded, the author aimed to 
analyze results under 50 hits. The titles and abstracts were then reviewed. If the findings 
did not directly correlate to the clinical questions at stake, the article was excluded. 
Duplicates were also discarded. After excluding articles based upon title and/or abstract, 
the remaining articles were then reviewed in entirety. Table 3 in the appendix lists the 
articles that were reviewed and the rationale as to why the article was included or 
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excluded. Multiple articles were excluded because the study did not specifically address women 
who had a BRCA gene mutation. Other articles were excluded because the sample included 
patients with diagnosed cancer, while the phenomenon of interest includes asymptomatic 
women.  
A total of 13 articles were included as they met the following inclusion criteria (a) 
subjects were women who carry a BRCA1 or BRCA2 gene mutation, (b) studies address the 
factors affecting decision-making in the management of cancer risk, (c) study subjects were 
asymptomatic, and (d) preventive surgical options such as mastectomy or salpingo-
oophorectomy were considered. The chosen articles were analyzed for level of evidence, key 
findings to answer the clinical question, and contributions to practice. The highest level of 
evidence obtained were cohort studies which is classified as Level IV evidence; four of these 
studies were included. Two meta-synthesis were included which are Level V evidence. Six of the 
articles included were qualitative studies and level VI evidence. For more details regarding the 
level of evidence, sample sizes, findings, and implications, see Table 4 in the appendices.  
Summary of the Literature 
A plethora of factors are brought to the forefront when a woman is faced with a BRCA 
genetic mutation. Women must choose between medical surveillance or surgical interventions to 
manage their personal cancer risk. How a woman perceives her cancer risk and makes decisions 
differs from one woman to the next. For some it is clear, obvious, and straightforward; for others 
the decision is complex, troublesome, and taxing. A process that can be determined in a matter of 
days for some, can persist for years for others. The following summary of the literature describes 
the elements affecting how a woman calculates her cancer risk and ultimately chooses between 
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ongoing medical surveillance and a surgical intervention upon receiving news of a positive 
BRCA mutation.  
Family Cancer History 
 A review of the literature revealed that the most common contributing factor to the 
decision-making process for women is the diagnosis of a close family member with cancer, as 
well as the death of a family member due to cancer. In a qualitative study including 64 
asymptomatic women with a BRCA-positive mutation, all of the women who chose surveillance 
over surgical intervention reported that they had no one close to them die from cancer (Hesse-
Biber & An, 2016). A few of the women in the surveillance category reported having a history of 
cancer in a relative; however the individual was not close to them or an emotional connection did 
not exist (Hesse-Biber & An, 2016). Interestingly, of the 40 women in this study who had a 
mother die from breast cancer, every single one chose preventive surgery over surveillance 
(Hesse-Biber & An, 2016). 
A cohort study completed by Singh et al. (2013) including 136 unaffected BRCA 
mutation carriers further suggests that family history impacts how women make decisions. The 
authors noted that even though sizeable research on the benefits of procedures like mastectomy 
and bilateral salpingo-oophorectomy exist, still more women opt to continue surveillance; 
therefore, the objective of the study was to explore the factors that affect decision-making for 
women (Singh et al., 2013). Those most likely to have a mastectomy were the women who had 
lost their mother to breast cancer (Singh et al., 2013). Women who had experienced the death of 
their mother from pelvic cancer elected for a bilateral salpingo-oophorectomy (Singh et al., 
2013). Overall, the findings were highly suggestive that a family history of cancer impacts how a 
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woman calculates her own cancer risk, even more so than actual risk estimations themselves 
(Singh et al., 2013).  
In a qualitative study including 10 BRCA positive women by McQuirter et al. (2010), 
family history of breast and ovarian cancer was again proven to have a profound effect on 
woman and alter decision-making. The study concluded that women often reach a “pivotal point” 
in decision-making (McQuirter et al., 2010). A previous experience such as cancer in a loved one 
is one of the pivotal situations where a decision to have a prophylactic surgery became definitive 
(McQuirter et al., 2010). One participant who had learned of her positive genetic mutation and 
decided to have a prophylactic mastectomy reported “My sister had a lot of trouble with 
chemo[therapy], so knowing what she went through… I don’t want to go through that” 
(McQuirter et al., 2010, p. 316). In addition, participants mentioned how the age their mother 
was diagnosed affected how they calculated their cancer risk; once they reached that specific age 
it felt as though a cancer diagnosis would happen any day (McQuirter et al., 2010). Reflecting on 
previous experiences of loved ones appears to instill fear into some women and inspire them to 
decisively undergo a preventative surgery.  
Johns et al. (2017) completed an observational study through retrospective chart review 
including 106 women who were BRCA positive and asymptomatic to better understand how 
women make decisions. They concluded that a diagnosis of cancer in a family member before 
the age of 50 or the death of a family member from cancer was linked to a decision to undergo 
preventive mastectomy (Johns et al., 2017). In their study, 36 of the participants underwent 
prophylactic mastectomy, while 70 of them chose surveillance (Johns et al., 2017). Overall, the 
occurrence of cancer in a family member plays a critical role for women in their viewpoint of 
self-risk ultimately impacting the decision-making process (Johns et al., 2017).  
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Life Stage  
The life stage of a woman impacts how decisions are made. When considering the 
treatment options, a woman must recognize her personal role and responsibility as a mother, 
wife, partner, sister, and daughter in the decision-making process (Howard et al., 2011). Women 
at younger ages have been shown to make different decisions than women who are older based 
on a variety of factors. These factors include relationship status, having children or a desire to 
have children in the future, and the personal value placed on body image and the role of the 
female body parts. Overall, the breasts and ovaries have multiple functions that women cherish; 
therefore, inspiring women to choose medical surveillance over a surgical option.  
Johns et al. (2017) found that women under age 30 more often choose surveillance over 
prophylactic mastectomy compared to those over age 30. Women under age 30 were recognized 
to place value on their breasts because of the desire to breastfeed in the future or for the overall 
physical appearance (Johns et al., 2017). For some women, the loss of breasts is associated with 
decreased self-esteem and feelings of “disfigurement” (Howard et al., 2011). In addition, women 
were concerned about the loss of breast sensitivity and pleasure, early menopause, and 
permanent infertility. These are all functional consequences that occur as a results of a risk-
reducing procedure (Howard et al., 2011). One participant in the study by Howard et al. (2011) 
stated the following: 
It’s [breast] part of my body. It fed my daughter, it’s part of me. I have a lot of fears and 
concerns with having surgery. I know most of them are silly or in my head. I think the 
biggest obstacle would be myself. Feeling that I’m not a woman, I’m not attractive. Will 
my husband still want me? (p. 509) 
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A woman experiences an internal battle with how to adapt to these functional consequences of 
risk-reducing surgery further complicating the decision-making process (Howard et al., 2011). It 
is important to consider that medical providers may not recommend a risk reducing surgery to 
younger populations because of these functional consequences (Johns et al., 2017). 
Leonarczyk and Mawn (2015) completed a qualitative study including 15 unaffected 
carriers of a BRCA1 or BRCA 2 gene. A theme emerging in their findings was that as the stage 
of life shifts for women, so does her risk, as do her attitudes toward significant relationships, 
marriage, and childbearing (Leonarczyk & Mawn, 2015). One participant highlighted the 
difference in decision-making based upon age: 
My daughter, having found out at age twenty-five, and me having found out at age fifty-
three is completely different. I was at lunch with two sisters last year and one of ‘em was 
married and one of ‘em was single and the single said, “I don’t know what I’m gona do”-
cause she was still trying to meet guys- so she said “I don’t want to have anything major 
done to my body.”  But the other sister who was married said “I’m gonna have my kids, 
two or three in a row, and then get all of this stuff taken out.” (Leonarczyk & Mawn, 
2015, p. 74)  
This quote validates how priorities change at different stages of life, ultimately affecting how 
women make decisions regarding preventative surgery.  
Child status and/or the desire to have children are a major component to decision-making. 
Parity appears to be associated with the uptake of a prophylactic surgery (Segerer et al., 2019; 
Singh et al., 2013). For a woman with any children at home, surgical interventions were often 
found to be the only option since women wanted to be assured they would be around for their 
children in the future (Hesse-Biber, 2014). The risk of cancer was too great and these women 
 14 
would rather undergo surgery than be faced with the possibility of being unable to watch their 
children grow (Hesse-Biber, 2014). Hesse-Biber and An (2016) found that the more guilt a 
woman felt about passing the gene along to a child, the more likely she would choose surgery 
over surveillance. In addition, those with daughters were more likely than those with only sons to 
have preventive surgery, as greater consideration was placed on passing along the BRCA gene to 
females (Hesse-Biber & An, 2016).  
If a woman has a desire to start a family, have more children, or breastfeed, then 
prophylactic mastectomy and/or oophorectomy are automatically removed from the treatment 
options. Ovarian cancer surveillance is the only choice for younger, premenopausal women who 
desire children because prophylactic oophorectomy results in infertility (Leonarczyk & Mawn, 
2015). Leonarczyk and Mawn (2015) reflected on this concept as one of their participants spoke 
of her decision to preserve fertility with the following: “I was like- there is no freakin way that 
this is gonna take my chance of ever having my own children” (p. 74). This is an important 
reason as to why some woman choose surveillance over any risk-reducing surgery. Of note, 
some women may choose surveillance for a period of time, and then decide to undergo a risk-
reducing surgery once they have fulfilled their life aspirations.   
Another factor impacting the decision-making process in women with positive BRCA 
findings is the level of family support she has. Hesse-Biber & An (2016) discussed that the less 
family support a woman experienced, the more likely she would continue with surveillance 
instead of risk-reducing surgery. Less family support can result in reduced urgency to make a 
decision and ultimately lead to delayed decision-making (Hesse-Biber & An, 2016). Overall, 
women are often found confiding in their support systems to determine the right treatment 
option. Howard et al. (2011) classified engagement with others as one of the decision-making 
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approaches that women use when deciding between treatment options. Women bounced thoughts 
off individuals close to them to sort through the complexities of their decision (Howard et al., 
2011). 
Psychosocial Factors 
The sense of fear harbored in women impacts the decision to undergo risk-reducing 
surgery. Hesse-Biber (2014) reported that emotional worry and fear are strong predictors in 
BRCA positive women to choose a surgical route. In a study by Portnoy and Loud (2015), 
individuals with increased breast cancer worry were found to be four times more likely to 
undergo a bilateral mastectomy in comparison to women with less worry. Women sometimes 
feel the only option to alleviate worry and fear is to have a surgery and choosing surgery over 
surveillance gives them a sense of control and provides comfort that the cancer threat is being 
eradicated (Hesse-Biber, 2014). Some women were fearful of becoming too emotionally drained 
when it came time to have a routine mammogram or MRI in that it could reveal cancer; 
moreover, they preferred a risk-reducing surgery (Hesse-Biber, 2014).   
The mental health of a woman affects how she makes decisions. If a women’s 
emotional health is suffering, she can’t effectively absorb information or make an informed 
decision. For women with high anxiety, it may prevent them from complying with surveillance 
guidelines (Padamsee et al., 2017). Those who feel poorly about themselves and their health 
were more inclined to choose a surgical intervention (Padamsee et al., 2017). Howard et al. 
(2011) found that increased worry and distress led to immediate decision making for some 
women in order to prevent further distress, while others waited until their mind was clearer to 
focus on the decision at stake.  
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             A cohort study by Portnoy and Loud (2015) of 120 BRCA positive women looked at 
how false-positive breast and ovarian cancer screening test results play a factor in how women 
make decisions. The findings demonstrated that false-positive test results from cancer screening 
instilled fear in women (Portnoy & Loud, 2015). Across the entire study, however, the worry of a 
false positive test result was not clearly linked to choosing a risk-reducing surgery (Portnoy & 
Loud, 2015). Overall, the most significant finding was that cancer-specific worry proved to be a 
strong predictor of surgery which is consistent with the previously discussed findings (Portnoy & 
Loud, 2015). 
What drives a woman to feel empowered and how she navigates the acceptance of 
increased cancer risk influences treatment decisions. For some women, the belief stands that 
“what is going to happen, will happen.” Women with this attitude may choose surveillance over 
surgical intervention because they feel cancer is inevitable and it will be dealt with when it 
happens. In the study by Hesse-Biber (2014), some of the women who chose surveillance 
reported that they integrated a positive BRCA diagnosis into their current life and came to terms 
with what it meant, ultimately accepting the mutation as who they are.  Some women felt they 
would not let a genetic mutation get in the way of their life and they would continue living life 
normally (Hesse-Biber, 2014). A response by one woman choosing surveillance over surgery 
was “We are a fix-it-up culture and sometimes we can’t fix things.  If cancer comes, it comes” 
(Hesse-Biber, 2014, p. 778). A common belief held by the women choosing surveillance is that 
life is greater than a genetic mutation (Hesse-Biber, 2014). For others, the decision-making was 
found to be in the hands of a higher power. These women looked to God or their personal 
religious beliefs to help guide them through the process (Hesse-Biber, 2014).  
Medical Professional Knowledge and Support 
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The recommendation of a health care professional can have a powerful effect on a 
woman’s decision-making. The significance of this advice is different among women. Some 
women will do extensive research on their own, while others will rely heavily on the medical 
professional for advice. A woman’s personality and style of obtaining information can alter how 
much trust is placed in the medical provider (McQuirter et al., 2010). The knowledge a health 
care professional has regarding the topic also affects how much trust a woman has and her 
willingness to partake in shared decision-making. Leonarczyk & Mawn (2015) found that 
participants were concerned about the lack of competent providers available to guide them along 
their decision-making process; this is particularly true in rural areas. When a lack of knowledge 
by the health care provider was sensed, women felt alone and that cancer risk management 
decisions fell largely on themselves (Leonarczyk & Mawn, 2015).  
Women in one study by Hesse & Biber (2014) expressed how health care professionals 
had a heavy influence on their decision-making. One participant felt that her provider  
seemed to prefer surgery over surveillance and gave the impression that cancer is inevitable for 
the BRCA positive patient (Hesse & Biber, 2014). Women who feel pressured to have surgery 
by their health care provider may not consider long-term medical surveillance because of the 
influence of the provider. Howard et al. (2011) found that women did not feel the health care 
professional offered enough support in the decision-making process. Health care professionals 
with more of a nondirect approach in their recommendations complicated the process for these 
women and forced them to make the decision on their own (Howard et al., 2011).  
A qualitative study by Puski et al. (2018) focused on the involvement of others in the 
decision-making process for BRCA positive women. Participants felt strongly about health care 
professionals’ engagement throughout the process and several women highlighted how 
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collaboration with a physician to interpret their risk led to feelings of reassurance during 
decision-making (Puski et al., 2018). Women want to trust their health care provider and confide 
in them for risk management decisions (Puski et al., 2018). Overall, the health care professional 
is in a powerful position to affect the decision-making process for women.  
Gaps in the Literature 
The intent of this literature search was to include only asymptomatic women in the 
decision-making process. A plethora of articles also included symptomatic women or those who 
had current cancer; however, a majority of these articles were excluded. By extending the 
population of interest to both symptomatic and asymptomatic women, additional perspectives 
could have been included within the evidence cited here. Having a current diagnosis of cancer 
significantly impacts decision-making and can alter the findings as these women are often driven 
to have surgery because of their diagnosis (Hesse-Biber, 2014). While there is evidence of a 
variety of factors contributing to the decision-making process for women carrying a BRCA 
mutation, more research is needed on strictly asymptomatic women.   
Another point to consider is that some women may choose a surgical option such as a 
mastectomy but wait to have a hysterectomy until later in life. These women are incorporating 
both a surgical option as well as medical surveillance which complicates the results of the 
clinical question. A more consistent approach such as studying decision-making of BRCA 
mutation carriers at specific ages may be useful. The limitations of the studies in this literature 
review included small sample sizes and participants that consisted of Caucasian, middle to upper 
class women. More research is needed to include women of all ethnicities and social classes to 
gain a broader understanding and increase the overall strength of the evidence.  
Discussion 
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Carrying a BRCA mutation is worry-some and anxiety provoking for many women. 
Women who carry a BRCA mutation are six times more likely to develop breast cancer than the 
average woman, and 28 times more likely to develop ovarian cancer (Johns et al., 2017). A 
woman must consider her individual cancer risk and ultimately make life-altering decisions. A 
review of the current literature depicts the plethora of factors that affect how women choose 
between medical surveillance and preventive surgery. It is important to note that women do not 
necessarily consider their cancer risk based on statistical odds, but rather to reframe their risk 
based upon a variety of other connections which influences their decision making (Hesse-Biber, 
2014). There is no solitary risk-reducing strategy that meets the expectations and concerns of all 
women; therefore, a variety of factors must be investigated (Salhab, 2010).  
A history of cancer in the family emerged as a powerful influence leading a woman to 
choose a preventive surgery. Watching the experiences of a loved one dealing with cancer, or 
even the death of a loved one from cancer causes a woman to be more fearful and, in many 
cases, leads to a quick, straightforward decision to undergo surgery. The age and stage of life a 
woman is in affects how decisions are made. Younger women are often more inclined to partake 
in increased medical surveillance which can be explained by multiple factors. Women of 
younger ages may not yet have children and desire to have them one day, which automatically 
removes an oophorectomy from the treatment options. For some women, maintaining functions 
of the breasts such as breastfeeding, providing pleasure, and heightening physical appearance led 
them to choose surveillance instead of a preventive surgery. Older women may be more willing 
to have a risk-reducing procedure as they are through the child-bearing years and may not place 
the same importance on body image.   
Other contributing factors impacting the decision-making process include a variety of  
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psychosocial factors and the level of influence of the health care professional. The amount of 
fear and anxiety one experiences affects how decisions are made; higher levels of worry and 
distress over carriage of the BRCA mutation are associated with a higher likelihood of a 
preventive surgery. Removing body parts and eliminating a cancer threat is a way to intervene 
for women with higher anxiety. For other women, having a BRCA genetic mutation doesn’t 
appear to have the same significance. These women will accept the fact that they are carriers of 
the mutation and not let the mutation stand in the way or affect how they live their life.    
The support and recommendations of the health care provider influence how women 
make decisions about treatment options. Women desire a health care professional that is 
knowledgeable and able to provide information about risk management. In addition, women 
want to foster a trusting relationship with the health care professional so that they can engage in 
shared decision-making. Women who did not feel supported by their health care provider feel 
alone in the decision-making process. Women who are less decisive about their treatment 
decision are more likely to rely heavily on the advice of the medical professional.  
Overall, a plethora of factors must be considered when a woman learns of a positive 
BRCA genetic mutation and must decide upon treatment options. The journey to reaching a 
decision requires women to weigh the pros and cons of each option and consider what is most 
important to them. The factors presented in this literature review will help readers understand the 
viewpoint of BRCA positive women and potentially help alleviate cancer-related distress for this 
population; therefore, informed decisions can be made regarding the risk-reducing strategies. 
Future Directions 
Implications for Practice 
The fear and anxiety of women surrounding a BRCA mutation can significantly impact  
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decision-making abilities. With increasing popularity of genetic testing, it is likely that more 
women will seek BRCA testing. Health care professionals, including advanced practice nurses, 
are in a key position to promote BRCA genetic testing and use their knowledge and expertise to 
support women during post-test decision-making. Ultimately, this can lead to earlier 
identification of cancer or prevention of cancer and improved health outcomes. Healthcare 
providers should have an understanding about the BRCA mutation and the treatment modalities 
that are available for BRCA positive patients. Decision-making among BRCA positive women is 
not a “one size fits all” type of process; a plethora of factors come into play when deciding on a 
strategy to reduce cancer risk (Hesse-Biber, 2014). This literature review identifies the key 
factors that contribute to decision-making for the woman carrying a BRCA mutation. By gaining 
awareness of these factors, health care providers can have a positive impact on women’s medical 
decision-making abilities and improve their overall health outcomes (Hesse-Biber & An, 2016). 
In addition, the health care provider can engage in shared decision-making with women resulting 
in decreased feelings of isolation during this process.  
A crucial consideration for health care providers is having awareness that a history of 
cancer in the family significantly impacts women’s decisions. Family cancer experiences for 
women may serve to guide decision-making even more so than any statistical odds or other 
medical recommendations (Hesse-Biber & An, 2016). Professionals should understand the 
impact of the family history and strive to discuss this with patients. Whether it be in discussions 
to pursue genetic testing or in providing support for women who have received positive BRCA 
results, favorable outcomes can be achieved with regards to cancer prevention. Research 
demonstrates the effectiveness of risk-reducing surgeries in preventing cancer; therefore, 
education and decisional support may result in increased uptake of these procedures.  
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Learning of a positive genetic test result causes acute distress for many women; therefore, 
the difficulties of decision-making may be further exacerbated. Women then desire to have more 
information about the treatment options and seek help in making decisions (Metcalfe et al., 
2017). Understanding the factors explored by this review of the literature opens up another area 
of future development. A standardized tool for decision-making could be used in the clinical 
setting to further support and empower women. A randomized control trail by Metcalfe et al., 
(2017) found that a decisional aid utilized for women carrying a BRCA mutation was linked to a 
significant decrease in cancer-related distress and decision-making when choosing between 
treatment options.  The decisional aid was a “15-page self-administered booklet that consists of 
key words and illustrative icons to summarize information and data regarding generic risk of 
breast cancer in BRCA1 and BRCA2 mutation carriers” (Metcalfe et al., 2017, p. 331).  The aid 
also included all the breast cancer preventive options available along with the risks and benefits 
of each strategy, the types of studies used to evaluate preventive options, and a side-by-side 
comparison of the pros and cons of each option (Metcalfe et al., 2017). Standardizing a tool of 
this kind to be used in the clinic setting would be highly valuable in decreasing decisional 
conflict in women carrying a BRCA mutation.  
Implications for Policy 
Health care policy changes will help support improved practice. Health care providers 
should have access to educational opportunities to further understand genetic testing and how to 
engage in shared decision-making to support post-test decisions. Not all individuals have access 
to genetic counselors; therefore, the primary care provider must have the ability to provide 
assistance too. Armstrong (2020) argues that now is the time for primary care providers to take 
responsibility in implementing BRCA genetic testing so that women have the opportunity to 
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learn of their risk before a diagnosis of cancer.  By increasing funding for educational programs 
and training, health care providers will be more knowledgeable in this area of practice while also 
increasing access of genetic services in rural communities.   
Individuals may lack access to appropriate and effective genetic testing due to 
cost. Whether or not insurance covers BRCA genetic testing significantly impacts who is able 
to undergo testing. Coverage by Medicaid and individual market plans are particularly 
inadequate (Armstrong, 2020). Under the Affordable Care Act, insurance companies are required 
to cover testing for women who meet specific criteria such as individuals with a personal cancer 
history or with a known family history of the  BRCA mutation (Armstrong, 2020). Even under 
these circumstances, the process to obtain approval for payment is extensive (Armstrong, 2020).  
Increased coverage for testing will be beneficial for a multitude of reasons. For women with 
cancer, it will help inform treatment decisions.  For women who are asymptomatic, learning of a 
positive BRCA mutation leads to either increased medical surveillance or a preventive surgery; 
both options result in improved health outcomes by earlier detection of cancer or elimination of 
the cancer threat.  
Implications for Research 
Multiples opportunities for future research exist as previously described through this 
review of the literature. More research is needed on strictly asymptomatic women. Since a cancer 
diagnosis strongly impacts women’s decisions, it is crucial for future studies to focus on 
decision-making for women who have not been diagnosed with cancer.  Research studies that 
focus on evaluating asymptomatic women have proven to be insightful; however, a greater 
number of studies with higher levels of evidence would help influence and expedite changes in 
practice and policy.  
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In order to gain a deeper understanding of decision-making, future research should aim to 
include women of all ethnicities. Individuals of all social classes and backgrounds should also be 
included to better capture decision-making from a variety of populations. Upon development of a 
standardized tool for decision-making, further research should consist of utilizing the tool in the 
practice setting and evaluating its effectiveness in a diverse context. Culture, education level, and 
socioeconomic status are all important features to consider for future research.   
Conclusion 
Although an immense amount of current research on the phenomenon of interest does 
not exist, the literature that is available is valuable in answering the clinical question being 
examined. The literature demonstrates that an array of factors come into play for women making 
decisions about whether a preventive surgery or medical surveillance is the best option for 
managing cancer risk with a BRCA mutation. A history of cancer in the family proves to be a 
strong indictor in the pursuit for a risk-reducing procedure. In addition, a woman’s life stage and 
a variety of psychosocial factors appear to play a critical role in the decision-making process. 
The knowledge and support of health care professionals affect how women make decisions.  
Overall, the process of decision-making for women is complex and deeply personal. Ultimately, 
it is the woman who makes the decision between prevention options; however, they look to 
health care professionals for advice in deciding which option to implement. Understanding the 
BRCA mutation, the risk reducing strategies, and how women make decisions is vital for health 
care providers caring for women impacted by positive BRCA findings. Engaging in shared 
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Intervention Findings Implications 
 
Hesse-Biber, S. (2014). The genetic 
testing experience of BRCA-positive 
women: Deciding between surveillance 
and surgery. Qualitative Health Research, 
24(6), 773-789. 



















N/A 49 women had preventive 
surgery and 14 did not . 
Those who did not have 
surgery felt there was no 
guarantee to develop 
cancer, and some were still 
wishing to have children. 
Other barriers were cost, 
lack of support from 
medical professionals, or 
lack of social support. 
Women do not follow a 
“medical” decision making 
model. Instead, women 
complete an assessment of 
their cancer risk with 
contributing factors of 
familial history, lived 
experience of family 
member dying from 
cancer, social support, and 
Health care professionals and 
organizations must understand that 
the decision making of BRCA + 
women is not a “one size fits all.” 
Many factors come into play. 
Women have discussed the 
struggles of putting their 
experiences and decision making 
into the medical system that did 
not meet their needs. A women’s 
perspective must be understood in 
order to empower women with 
BRCA positive status. 
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information from social 
network. 
Hesse-Biber, S., & An, C. (2016). Genetic 
testing and post-testing decision making 
among BRCA-positive mutation women: 
A psychosocial approach. Journal of 








options and to 
what extent do 
psychosocial 
factors influence 
the time at which 
women choose 
surgery 
















N/A Women without children 
were more likely to have 
the surgery than those with 
only sons; Those with 
daughters were more 
likely to have the surgery. 
The more distress a 
women was over positive 
BRCA results, the less 
likely to get surgery and 
more likely to continue 
surveillance. The more 
uncertain about familial 
support, the less likely a 
woman was to have 
preventive surgery. This 
was also true for medical 
uncertainty. The more 
guilty a woman felt about 
passing trait to children, 
the more likely to undergo 
surgery. 
In order to maximize cancer 
prevention strategies, clinicians 
must understand the decision 
making from a women’s 
standpoint. Utilizing a feminist 
approach that highlights specific 
psychosocial factors in regards to 
medical decision making for risk 
reducing surgery is an important 
step forward. It may empower 
women’s medical decision making 
abilities and improve overall 
outcomes.  
Howard, A. F., Balneaves, L.G., Bottorff, 
J.L., & Rodney, P. (2011). Preserving the 
self: The process of decision making about 
hereditary breast cancer and ovarian 
cancer risk reduction. Qualitative Health 
























N/A Overall, the decision-
making process is directed 
toward preserving self; 
These included physical 
health, self-identity as a 
woman, relationships with 
others, and emotional 
well-being.  
The findings of preserving self 
provides direction of decision 
support. A women’s decision goes 
beyond strictly physical health and 
includes a woman’s self-identity, 
her emotional well-being, and her 
relationships with others. 
Information based approaches are 
less likely to be successful than 
those using psychosocial 
interventions that help with coping 
and adjustment. 
Johns, D., Agarwal, J., Anderson, L., 
Ying, J., & Kohlmann, W. (2017). Breast 
cancer reduction decisions of the BRCA- 
positive patient: An observational study at 
a single institution. Journal of Women’s 






cancer risk made 
by patients who 
are BRCA 
mutation positive 































N/A Risk reducing strategy is a 
very personal decision; 
Age of the patient, relative 
with breast cancer or death 
of a relative before age 50, 
and prophylactic 
oophorectomy all pay role 
in which reduction 
strategy is chosen. Patients 
less than 30 often 
proceeded with 
surveillance. This age 
there is greater desire to 
keep breasts for 
The decision making process is 
complex and a highly personal 
decision involving a variety of 














appearance.  A personal 
family history of cancer 
plays an important role in 
perceived self-risk. If a 
patient undergoes one risk 
reducing surgery, they are 
more likely to opt for 
others.  
Leonarczyk, T.J., & Mawn, B. E. (2015). 
Cancer risk management decision making 
for BRCA + women. Western Journal of 
Nursing Research, 37(1), 66-84. 





for women who 
are unaffected 














Level VI  
Interviews-  
25-60 
minutes; 9 in 
person and 6 
by telephone; 
Videotaped 
N/A Fear related to family 
experiences with cancer, 
body image, and concerns 
about fertility are factors 
affecting decision making. 
Urgency to have intimate 
relationships and complete 
childbearing before 
prophylactic surgery were 
other factors.  
There is a need for knowledge and 
support by health care providers in 
this area. Telehealth can connect 
support systems to rural 
communities where resources are 
limited.  
McQuirter, M., Castiglia, L.L., Loiselle, 
C.G., & Wong, N. (2010). Decision-
making process of women carrying a 
BRCA1 or BRCA2 mutation who have 
chosen prophylactic mastectomy. 
Oncology Nursing Forum, 37(3), 313-320 
To look at the 
decision making 
process of BRCA 

























N/A Pivotal points to 
definitively have a 
mastectomy were testing 
positive for a mutation, 
having a personal history 
of breast cancer, or having 
a family member with 
breast cancer. Emotions 
play a vital role in decision 
making; It is more 
complicated than weighing 
the pros and cons. Anxiety 
and worry come into play.  
Awareness of pivotal points may 
assist nurses and health care 
professionals  
Metcalfe, K.A., Dennies, C.L., Poll, A., 
Armel, S., Demsky, R., Carlsson, L., 
Nanda, S., Kiss, A., & Narod, S.A. (2017). 
Effect of decision aid for breast cancer 
prevention on decisional conflict in 
women with a BRCA1 or BRCA2 
mutation: A multisite, randomized, 
controlled trial. Genetics in Medicine: 
Official Journal of the American College 
of Medical Genetics, 19(3), 330-336. 
BRCA ½ women 
must make 
critical decisions 
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for breast cancer 
prevention in 






































The tool did not reduce 
decision conflict, but was 
effective in decreasing 
cancer-related distress in 
the year following a 
receipt of positive genetic 
test results. Cancer related 
distress is elevated in the 
positive BRCA ½ patient 
but it declines over time.  
The tool provided lower 
levels of long term cancer 
related stress in 
comparison to usual care.  
Utilizing a decisional aid can 
better support women and reduce 
cancer related distress when 
compared with usual care 
especially for women who are 







Padamsee, T.J., Wills, C.E., Yee, L.D., & 
Paskett, E.D. (2017). Decision making for 
breast cancer prevention among women at 
elevated risk. Breast Cancer Research, 
19(34), 1-12. 
To examine the 
various 
approaches high 
risk women use 
in cancer risk 
management and 
the drivers of 
their decisions 
N/A Meta synthesis 
Level V 
N/A N/A The processing of accurate 
information is crucial in 
order for women to make 
appropriate decisions. 
Better informed women 
make different decisions in 
comparison to those where 
shared decision making 
did not take place. 
Providers often provide 
less information than high 
risk women want. Intuitive 
and emotional decision 
making, shaped by 
personal experience and 
instincts is usually 
dominant over the 
conscious, analytic style of 
decision making. 
Research findings can help 
support and empower women to 
make informed and value- 
consistent decisions and move 
towards favorable health outcomes 
Portnoy, D.B., Loud, J.T., Han, P.K.J., 
Mai, P.L., & Greene, M.H. (2015). Effects 
of false-positive cancer screenings and 
cancer worry on risk-reducing surgery 
among BRCA ½ carriers. Health 
Psychology, 34(7), 709-717. 
To examine (a) 







risk and worry 
(b) the joint 
effect of FPTR, 
risk perception, 
and worry on the 





























(Likert type)  
N/A False positive results were 
not associated with opting 
for risk-reducing surgery  
 BRCA positive women worried 
about their cancer risk and in turn 
was associated with choosing 
surgical management 
Puski, A., Hovick, S., Senter, L., & 
Toland, A.E. (2018). Involvement and 
influence of healthcare providers, family 
members, and other mutation carriers in 
the cancer risk management decision-
making process of BRCA1 and BRCA2 
To examine gene 
carrier decision 
making in cancer 
risk management 
and the role of 
others in the 
decision making 
















N/A Physicians, family 
members, and other 
mutation carriers were 
found to play an important 
role in the decision making 
process for surgical 
intervention. 
Women with BRCA 1 or 2 
mutation who have not had 
cancer, are under age 40, and/or 
do not have current children are 
found to have a more difficult 
time throughout the decision-
making process of risk 
management. A genetic counselor 
 35 
mutation carriers. Journal of Genetic 
Counseling, 27(5), 1291-1301. 
may help ease the decision making 
process.  
Salhab, M., Bismohun, S., & Mokbel, K. 
(2010). Risk-reducing strategies for 
women carrying BRCA ½ mutations with 
a focus on prophylactic surgery. BMC 








The aim of this 










N/A N/A Cancer risk, survival, and 
overall quality of life are 
the important factors 
considered for making a 
good decision on risk-
reducing strategies. Non-
surgical options provide a 
good body image and a 
quality of life but can be 
found to increase risk of 
advanced stage cancer and 
mortality. The surgical 
route ensures high 
protection from cancer 
however is associated with 
a number of disadvantages 
of invasiveness, non-
reversibility, and surgical 
morbidity. 
The management of BRCA 
positive mutation carriers is 
challenging; It should consider a 
woman’s expectations and 
preferences. These preferences 
can be informed by good 
knowledge or the risk and benefits 
of the options considered. 
Segerer, R., Peschel, C., Kammerer, U., 
Haussler, S., Wockel, A., & Segerer, S. 
(2020). Factors impacting on decision-
making towards prophylactic surgeries in 
BRCA mutation carriers and women with 




















N/A Diagnosed cancer, cancer 
in the family, fear of 
getting cancer and 
assumed better benefits are 
factors leading to 
preventive surgery. 
Reasons for surveillance 
include importance of 
physical appearance, fear 
of rejection of partner, fear 
of disordered female 
identity, fear of never 
feeling healthy again etc.  
Education on the benefits of 
surgery and reducing overall fear 
should take place as prophylactic 
surgery has been shown to reduce 
cancer incidence in comparison to 
periodic screening 
Singh, K., Lester, J., Karlan, B., Bresee, 
C., Geva, T., & Gordon, O. (2013). Impact 
of family history on choosing risk-
reducing surgery among BRCA mutation 
carriers. American Journal of Obstetrics & 




































N/A Family history has a 
significant impact on the 
uptake of risk-reducing 
surgeries among BRCA 
mutation carriers. Women 
who lost their mother to 
breast cancer were more 
likely to have risk-
reducing mastectomy and 
those who lost mother to 
pelvic cancer were more 
likely to have risk-
reducing bilateral 
salpingo-oophorectomy. 
Overall, perception of 
cancer risk is heavily 
With the increase in BRCA testing 
by primary care providers, the 
awareness of subtle factors 
beyond statistical risk for cancers 
is relevant when providing support 
and counseling to at risk women. 
Providers should educate the 
patient regarding her risk, but also 
understand the attitudes 













associated with a family 
history and are motivators 
of preventive surgery. 
Having children  also 
found to be associated 
with uptake of 
prophylactic surgery. 
